News for Biomerica, Inc. (BMRA)

Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sa

**media[598042]**

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 200 points on Wednesday. The Dow traded down 0.55% to 40,145.06 while th...

Biomerica, Inc. (BMRA) has declared a reverse stock split, consolidating its shares on a 1-for-8 basis. This adjustment will take effect from April 21, 2025. Po

\n Biomerica (BMRA) will execute a 1-for-8 reverse stock split effective April 21, 2025. The split is intended to help regain compliance with Nasdaq's mini

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 2% on Wednesday. The Dow traded down 0.67% to 40,099.73 while the NASDAQ dipped 2...

\nShares Expected to Begin Trading on Split-Adjusted Basis on April 21, 2025\n\nIRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. ( BMRA) (â\u0080\u009cBi

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA) (

PR NewswireBOTHELL, Wash., March 18, 2025 BOTHELL, Wash., March 18, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"

Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and al

U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29.

January 16, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including b...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Thursday. The Dow traded down 0.27% to 43,106.65 while...

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 0.1% on Thursday. The Dow traded up 0.08% to 43,256.69 while the NASDA...

U.S. stocks traded slightly lower this morning, with the Dow Jones index falling around 0.2% on Thursday. Following the market opening Thursday, the Dow traded...

- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer - Prostate Cancer: The Second Most Common

- Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings

New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn's Disease ($2.5 billion+), and Ulcerative

**media[459326]**